BLINCYTO
blinatumomab · KIT · Amgen, Inc
No Recall History
Plain English
BLINCYTO is a kit containing blinatumomab. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- BLINCYTO
- Generic Name
- blinatumomab
- NDC Code (Product)
55513-160- Manufacturer
- Amgen, Inc
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125557
- Marketing Start
- 12/18/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is BLINCYTO used for?
BLINCYTO contains blinatumomab. It is a kit taken as directed. Consult your doctor for specific uses.
Is BLINCYTO a controlled substance?
BLINCYTO is not classified as a controlled substance by the DEA.
What is the generic name for BLINCYTO?
The generic name for BLINCYTO is blinatumomab. There are no other listed brand versions of blinatumomab.
What is the NDC code for BLINCYTO ?
The NDC (National Drug Code) for BLINCYTO is 55513-160, listed by Amgen, Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)